Literature DB >> 17296440

Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma.

Young Deuk Choi1, Nam Hoon Cho, Hyun Soo Ahn, Kang Su Cho, Soung Yong Cho, Won Jae Yang.   

Abstract

PURPOSE: Superficial bladder transitional cell carcinoma has a high recurrence rate following endoscopic resection. Most parameters used to predict recurrence are associated with high grade transitional cell carcinoma. However, there are few valid parameters for predicting low grade transitional cell carcinoma recurrence. We elucidated the prime factor in recurrent superficial low grade bladder transitional cell carcinoma.
MATERIALS AND METHODS: A total of 40 cases of superficial low grade bladder transitional cell carcinoma were analyzed, including 20 recurrent and 20 nonrecurrent cases. Fresh frozen tumor and normal tissues were used. Real-time reverse transcriptase-polymerase chain reaction and Western blots were performed subsequently to evaluate the validity of molecules identified by 0.12K cDNA array composed of matrix metalloproteinase, oncogenes and cell cycle related genes.
RESULTS: On cDNA microarray analysis matrix metalloproteinase-1, 2, 9, 12 and 15, transforming growth factor-beta1, vascular endothelial growth factor and fos were found to be significantly up-regulated in recurrent cases. On real-time reverse transcriptase-polymerase chain reaction to validate those molecules matrix metalloproteinase-1 and 12, transforming growth factor-beta1, vascular endothelial growth factor and fos were significantly over expressed in recurrent cases. Western blot showed significant over expression of matrix metalloproteinase-1 and 12, transforming growth factor-beta1, vascular endothelial growth factor and fos in recurrent cases.
CONCLUSIONS: Over expression of matrix metalloproteinase-1 and 12, transforming growth factor-beta1, vascular endothelial growth factor and fos may be associated with the recurrence of superficial low grade bladder transitional cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296440     DOI: 10.1016/j.juro.2006.10.031

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  Matrix metalloproteinases and their clinical relevance in urinary bladder cancer.

Authors:  Tibor Szarvas; Frank vom Dorp; Süleyman Ergün; Herbert Rübben
Journal:  Nat Rev Urol       Date:  2011-04-12       Impact factor: 14.432

2.  Inhibition of TGF-beta receptor I by siRNA suppresses the motility and invasiveness of T24 bladder cancer cells via modulation of integrins and matrix metalloproteinase.

Authors:  Yubing Li; Kai Yang; Qiqi Mao; Xiangyi Zheng; Debo Kong; Liping Xie
Journal:  Int Urol Nephrol       Date:  2009-08-08       Impact factor: 2.370

3.  Afatinib inhibits proliferation and invasion and promotes apoptosis of the T24 bladder cancer cell line.

Authors:  Yunhua Tang; Xiangyang Zhang; Fan Qi; Mingfeng Chen; Yuan Li; Longfei Liu; Wei He; Zhuo Li; Xiongbing Zu
Journal:  Exp Ther Med       Date:  2015-02-25       Impact factor: 2.447

4.  Spotlight on differentially expressed genes in urinary bladder cancer.

Authors:  Apostolos Zaravinos; George I Lambrou; Dimitrios Volanis; Dimitris Delakas; Demetrios A Spandidos
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

Review 5.  Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis.

Authors:  Chenkui Miao; Chao Liang; Jundong Zhu; Aiming Xu; Kai Zhao; Yibo Hua; Jianzhong Zhang; Wei Chen; Chuanjian Suo; Chao Zhang; Yiyang Liu; Shifeng Su; Zengjun Wang
Journal:  Oncotarget       Date:  2017-05-09

Review 6.  TGF-β and microRNA Interplay in Genitourinary Cancers.

Authors:  Joanna Boguslawska; Piotr Kryst; Slawomir Poletajew; Agnieszka Piekielko-Witkowska
Journal:  Cells       Date:  2019-12-12       Impact factor: 6.600

7.  Gallic acid inhibits bladder cancer cell proliferation and migration via regulating fatty acid synthase (FAS).

Authors:  Chung-Chia Liao; Shu-Chun Chen; Hui-Pei Huang; Chau-Jong Wang
Journal:  J Food Drug Anal       Date:  2017-07-08       Impact factor: 6.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.